Dear [medical expert name],
Are you planning to attend AAN 2023? The
Novartis team will be there, and we hope
you’ll join us!
Join our symposium to discover more about
Novartis’ commitment to multiple
sclerosis.
Our Medical Directors, Dr Jason Freeman, Dr
Brandon Brown, Dr Gina Cox, and Dr Stephen
Yeung, from Novartis Neuroscience Medical
Affairs will discuss latest updates on
multiple sclerosis therapies, including
novel and prospective therapies and
biomarkers for multiple sclerosis.
Dr Jason Freeman, Dr Brandon Brown, Dr Gina
Cox, and Dr Stephen Yeung will be
presenting on Monday, April
24th at 6:00 ᴘᴍ ET at the Aloft Boston Seaport
District hotel in the Mann Ballroom.
|
|
Save the date and register by
April 24th to join us. All
attendees must be registered for the meeting
to access this symposium.
We hope to see you there!
|
|
Please note that no CME will be given
by any accredited organization for
attending. Additionally, Industry
Therapeutic Updates program content and
the views expressed herein are those of
the presenting corporate entity and not
of the AAN. These programs are not an
official part of the 2023 AAN Annual
Meeting education or scientific
programs, nor are they endorsed by the
AAN. The AAN cannot affirm claims
pertaining to FDA off-label medication,
research use of pre-FDA drugs, or other
research information that might be
discussed. Industry Therapeutic Updates
are industry events.
Novartis Pharmaceuticals Corporation
(NPC) may not be able to offer you food
or beverages if you are licensed by a
state with a meal limit or prohibition,
if you are a government employee or
member of a formulary committee, or if
your institution or affiliation
prohibits your acceptance of a meal from
a pharmaceutical industry
representative. NPC relies on you to
ensure mutual compliance with all
applicable laws and policies.
Novartis acts in accordance with the
PhRMA Code on Interactions with Health
Care Professionals. The PhRMA Code
states that inclusion of a health care
professional’s spouse or guest at an
educational program is not appropriate.
Your support of these ethical guidelines
will help to provide a high-quality
learning environment for all
participating health care professionals.
Thank you.
|
|
|
|
